How to use Technology Searches
The `Technologies Searched´-section displays profiles of unmet needs covering a broad spectrum from scientific expertise to clinical stage product candidates. Text search allows the use of phrases not yet part of our category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in `Sector´, "Cancerous, neoplasmatic" in `Disease Category, "Drugs, Small Molecule" in `Technology´ and "Preclinical" in `Development Stage. Selection of "Enabling Technology, Platform technology" in `Sector´ will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee. Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Summary
Genmab is seeking validated antigenic targets available for the development of fully human antibodies
Organization name
Genmab A/S business development
Profile
Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases.
Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products.
Genomics and other research techniques, such as proteomics, are leading to the discovery of an unprecedented number of potential disease targets. Genmab´s ability to quickly convert interesting targets into antibody products has attracted numerous partners.
To maximize the value of their integrated human antibody development capabilities, Genmab is forming collaborations with other biotechnology and pharmaceutical companies to co-develop antibody products to novel disease targets.
Additional information is provided online.
URL
http://www.genmab.com/ContactGenmab/Contact%20Genmab.aspxYour feedback
back
print this page
